|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
RATE OF CHANGE
Trading: SELL @ $0.16
Signal Strength: MEDIUM
Impedimed (ASX:IPD) currently has negative rate of change of -21.951%. This means the current price is less than the price 14 days ago and therefore losing momentum.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement
Rate of Change (ROC) is a refinement of Momentum - readings fluctuate as percentages around the zero line. The indicator is designed for use in ranging markets - to detect trend weakness and likely reversal points. However when combined with a trend indicator it can be used in trending markets.
Calculation: Rate of Change (ROC):
1) (Closing Price [today] - Closing Price [n days ago]) / Closing Price [n days ago] * 100
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
|OCL Objective Corporation||6.49||10||35,078||-6.29||BEARISH|
|MCY Mighty River Power||5||7.1||7,917||-0.65||BEARISH|
|LNG Liquefied Natural Gas||0.21||5.1||2,729,105||-16.67||BEARISH|
|MEZ Meridian Energy||4.9||4.4||46,590||-2.71||BEARISH|
|TBR Tribune Resources||6.24||4.2||96,157||-4.72||BEARISH|
|PNR Pacific Niugini Minerals||0.14||3.7||2,478,287||-11.94||BEARISH|
|GTN GTN Resources||0.7||3.7||7,121||-1.96||BEARISH|
|PGC Paragon Care||0.45||3.5||206,495||-5.14||BEARISH|
|BLX Beacon Lighting||1.23||3.4||22,040||-0.92||BEARISH|